Skip to main content
20 Nov | 2020

The BBRC incorporates new members to its Scientific Advisory Board

The advisory board is composed of renowned researchers in the field of Alzheimer’s disease and neurodegenerative diseases

10 Nov | 2020

BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease

An international team of researchers, led at the BBRC, has discovered that a series of biomarkers recently described to detect the most advanced phase of Alzheimer's can also detect the preclinical phase of the disease in the cerebrospinal fluid and plasma.

28 Oct | 2020

The BBRC receives the European Commission award 'HR Excellence in Research'

The award recognizes the commitment of the research center with the principles set out in the European Charter for Researchers and the Code of Conduct for the Recruitment of research staff.

28 Sep | 2020

Avalanche of data against Alzheimer's

The digitization of the data collected in our studies allows us to accelerate our research, improve its integrity and make it available to researchers around the world.

16 Sep | 2020

The FDA accepts license application for aducanumab, the first possible disease modifying drug for Alzheimer’s

Dr José Luis Molinuevo comments the possible approval of Biogen’s new treatment, in an interview for the podcast Saving Minds.

04 Sep | 2020

Marc Suárez-Calvet is awarded an ERC Starting Grant to identify age-related blood factors as a therapeutic target for Alzheimer’s disease

The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor

07 Aug | 2020

BBRC presents more than 20 studies at the Alzheimer's Association International Conference 2020

The most prominent congress dedicated to Alzheimer's research has been held completely virtual

03 Aug | 2020

Proximity to parental age at onset of Alzheimer's indicates an increased risk of developing the disease in women

The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy